NCT06067321

Brief Summary

The safety implications of prolonged fasting in young children prior to general anaesthesia are well described. Current UK guidance recommends a fasting time of 6 hours for formula milk prior to general anaesthesia. European guidance published in 2022 recommended a reduced fast of 4 hours for infants taking formula milk, albeit with a downgraded level 2B of evidence given the paucity of high quality research in this area. Although pulmonary aspiration of gastric contents under anaesthesia in children is a rare event, animal studies suggest that aspiration of particulate matter at volumes greater than 0.8 ml/kg gastric volume are associated with demonstrable lung injury and mortality. Although rate of gastric emptying of formula preparations has been extensively studied in neonatal intensive care settings for preterm babies using ultrasound, few studies have measured gastric volume directly in healthy term infants undergoing anaesthesia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 4, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

October 4, 2023

Status Verified

September 1, 2023

Enrollment Period

1 year

First QC Date

September 14, 2023

Last Update Submit

September 28, 2023

Conditions

Keywords

gastricvolume

Outcome Measures

Primary Outcomes (1)

  • gastric residual volume

    aspiration of gastric contents via naso-gastric tube

    following induction, pre surgery

Secondary Outcomes (1)

  • antral cross sectional area

    pre induction

Study Arms (2)

4 hours formula feed

ACTIVE COMPARATOR

Parents asked to offer formula feed 4 hours prior to anticipated procedure start

Other: abdominal ultrasound, insertion of naso-gastric tube

6 hour formula feed

ACTIVE COMPARATOR

Parents asked to offer formula 6 hours prior to anticipated procedure start

Other: abdominal ultrasound, insertion of naso-gastric tube

Interventions

measurement antral cross sectional area, volume and pH of residual stomach contents

4 hours formula feed6 hour formula feed

Eligibility Criteria

AgeUp to 1 Year
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Term or term corrected (\> 37 weeks) upto 12 months Formula fed ASA 1-3

You may not qualify if:

  • Significant reflux Co-administration of drugs known to impact gastric motility or PH of gastric contents Significant respiratory comorbidity including chronic lung disease on home oxygen Significant cardiac comorbidity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emily Saffer

London, Greater London, SE5 9RS, United Kingdom

Location

MeSH Terms

Conditions

FastingPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Condition Hierarchy (Ancestors)

Feeding BehaviorBehaviorLeukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 14, 2023

First Posted

October 4, 2023

Study Start

May 1, 2024

Primary Completion

May 1, 2025

Study Completion

July 1, 2025

Last Updated

October 4, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations